The pharmaceutical company has asked the American and European authorities to authorize the use of the vaccine, ensuring that in the most severe cases the effectiveness is 100%
The North American pharmaceutical Moderna requested this Monday the authorization for the use of its vaccine against the covid-19, after having been confirmed that the effectiveness is of 94,1%. In this regard, the company asked the American authorities (FDA) to use the vaccine in an emergency, as well as conditional approval by the European Medicines Agency.
Preliminary results were published two weeks ago that put the vaccine’s effectiveness at 94.5%, but the American company now announces that no safety problem has been reported, which is why it has a 100% success rate in preventing serious cases , with more severe symptoms. “This positive primary analysis confirms our vaccine’s ability to prevent covid-19 disease with 94.1% effectiveness and, most importantly, its ability to prevent severe cases of covid-19. We believe that our vaccine will provide a new and powerful tool that will change the course of this pandemic and help prevent serious cases, hospitalizations and deaths ”, justified Stéphane Bancel, executive director of Moderna.
Read more in Diário de Notícias
This article is available in: Português